CRISPR screening uncovers a long-range enhancer for ONECUT1 in pancreatic differentiation and links a diabetes risk variant.

We observed a noticeable trend toward a decrease, but the difference did not reach statistical significance ( Figure S3A ), which may be attributed to the low expression of WDR72 at the PFG stage.

also in 111,027 other papers